TARRYTOWN, N.Y., Feb. 13, 2017 /PRNewswire/ -- Regeneron
Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management
presentations at the following investor conferences:
- Leerink Partners 6th Annual Global Healthcare
Conference at 10:30 a.m. Eastern Time
on Thursday, February 16, 2017
- Raymond James 38th
Annual Institutional Investors Conference at 1:05 p.m. Eastern Time on Monday, March 6,
2017
The sessions may be accessed through the Company's web site,
www.regeneron.com, on the 'Events and Presentations' page.
Archived versions of the presentations will be available for 30
days.
About Regeneron Pharmaceuticals, Inc.
Regeneron
(NASDAQ: REGN) is a leading science-based biopharmaceutical company
that discovers, invents, develops, manufactures and commercializes
medicines for the treatment of serious medical conditions.
Regeneron commercializes medicines for eye diseases, high LDL
cholesterol and a rare inflammatory condition and has product
candidates in development in other areas of high unmet medical
need, including rheumatoid arthritis, atopic dermatitis, asthma,
pain, cancer and infectious diseases. For additional information
about the company, please visit www.regeneron.com or follow
@Regeneron on Twitter.
|
Contact
Information:
|
|
|
|
|
Investor
Relations
|
Corporate
Communications
|
|
Manisha Narasimhan,
Ph.D.
|
Hala Mirza
|
|
914.847.5126
|
914.847.3422
|
|
manisha.narasimhan@regeneron.com
|
hala.mirza@regeneron.com
|
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/regeneron-announces-upcoming-2017-investor-conference-presentations-300406009.html
SOURCE Regeneron Pharmaceuticals, Inc.